- Home
- PAR vs PTGX Comparison
PAR vs PTGX Comparison
Compare PAR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAR
- PTGX
- Stock Information
- Founded
- PAR 1968
- PTGX 2006
- Country
- PAR United States
- PTGX United States
- Employees
- PAR N/A
- PTGX N/A
- Industry
- PAR Office Equipment/Supplies/Services
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- PAR Miscellaneous
- PTGX Health Care
- Exchange
- PAR Nasdaq
- PTGX Nasdaq
- Market Cap
- PAR 2.2B
- PTGX 2.8B
- IPO Year
- PAR N/A
- PTGX 2016
- Fundamental
- Price
- PAR $62.35
- PTGX $43.92
- Analyst Decision
- PAR Strong Buy
- PTGX Strong Buy
- Analyst Count
- PAR 7
- PTGX 8
- Target Price
- PAR $81.86
- PTGX $66.50
- AVG Volume (30 Days)
- PAR 343.3K
- PTGX 1.1M
- Earning Date
- PAR 05-09-2025
- PTGX 05-06-2025
- Dividend Yield
- PAR N/A
- PTGX N/A
- EPS Growth
- PAR N/A
- PTGX N/A
- EPS
- PAR N/A
- PTGX 0.86
- Revenue
- PAR $349,982,000.00
- PTGX $207,801,000.00
- Revenue This Year
- PAR $30.31
- PTGX N/A
- Revenue Next Year
- PAR $16.16
- PTGX $7.13
- P/E Ratio
- PAR N/A
- PTGX $50.92
- Revenue Growth
- PAR 26.48
- PTGX N/A
- 52 Week Low
- PAR $37.74
- PTGX $24.22
- 52 Week High
- PAR $82.24
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- PAR 60.27
- PTGX 46.05
- Support Level
- PAR $58.12
- PTGX $41.29
- Resistance Level
- PAR $61.97
- PTGX $46.12
- Average True Range (ATR)
- PAR 1.83
- PTGX 1.78
- MACD
- PAR 0.67
- PTGX -0.17
- Stochastic Oscillator
- PAR 87.85
- PTGX 43.48
About PAR PAR Technology Corporation
PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.